AgeRejuvenation Uses Tesamorelin to Reduce Visceral Fat

AgeRejuvenation offers treatments utilizing the peptide tesamorelin, aimed at reducing deep abdominal fat and improving body composition. The treatment is part of AgeRejuvenation's supervised aging wellness programs, focusing on metabolic health.

Tesamorelin functions as a GHRH (Growth Hormone-Releasing Hormone) analog. It signals the body to release its own growth hormone, with a specific effect on shrinking visceral fat around the organs while preserving lean muscle mass. This can lead to a reduction in waist circumference, even if total body weight does not change significantly.

Visceral fat, which accumulates in the abdominal cavity around organs, has been linked to increased inflammation, insulin resistance, and a higher risk of cardiovascular diseases. Factors such as hormonal shifts, decreased muscle mass, and poorer sleep quality associated with aging can contribute to its accumulation, even with stable diet and exercise habits.

AgeRejuvenation emphasizes that tesamorelin is administered under clinical supervision. The therapy is intended to support a comprehensive plan for healthy aging, which may also involve optimizing diet and exercise.